Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Pathogens (Basel, Switzerland)|February 25, 2023
COVID-19 Vaccination and Alcohol Consumption: Justification of RisksPavel A Solopov
The American Journal of Pathology|March 30, 2022
The Inflammasome NLR Family Pyrin Domain-Containing Protein 3 (NLRP3) as a Novel Therapeutic Target for Idiopathic Pulmonary FibrosisRuben M L Colunga Biancatelli, Pavel A Solopov, John D Catravas
The American Journal of Pathology|April 28, 2022
Alcohol Increases Lung Angiotensin-Converting Enzyme 2 Expression and Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Subunit 1-Induced Acute Lung Injury in K18-hACE2 Transgenic MicePavel A Solopov, Ruben M L Colunga Biancatelli, John D Catravas
SLAS Discovery : Advancing Life Sciences R & D|February 16, 2023
An acute respiratory distress syndrome drug development collaboration stimulated by the Virginia Drug Discovery ConsortiumJohn S Lazo, Ruben M L Colunga-Biancatelli, Pavel A Solopov, et al.
Frontiers in Pharmacology|November 24, 2022
Optimizing antidotal treatment with the oral HSP90 inhibitor TAS-116 against hydrochloric acid-induced pulmonary fibrosis in micePavel A Solopov, Ruben Manuel Luciano Colunga Biancatelli, Christiana Dimitropolou, et al.
Research Square|August 26, 2024
A Novel Non-Rodent Animal Model of Hydrochloric Acid-Induced acute and chronic lung injuryPavel A Solopov, Ruben Manuel Luciano Colunga Biancatelli, Tierney Day, et al.
Frontiers in Physiology|April 7, 2022
HSP90 Inhibitors Modulate SARS-CoV-2 Spike Protein Subunit 1-Induced Human Pulmonary Microvascular Endothelial Activation and Barrier DysfunctionRuben Manuel Luciano Colunga Biancatelli, Pavel A Solopov, Betsy Gregory, et al.
Respiratory Research|October 30, 2024
A novel Non-rodent animal model of hydrochloric acid-induced acute and chronic lung injuryPavel A Solopov, Ruben Manuel Luciano Colunga Biancatelli, Tierney Day, et al.
Cancers|May 27, 2026
Establishment and Histopathological Characterization of a KYSE-30 Subcutaneous Xenograft Model of Esophageal Squamous Cell CarcinomaPavel A Solopov, Alayna Enos, Mantas Silkunas, et al.
Frontiers in Pharmacology|July 6, 2026
Targeting PTP4A3 with KVX-053 mitigates alcohol-amplified SARS-CoV-2 spike protein-induced acute lung injuryPavel A Solopov, Ruben Manuel Luciano Colunga Biancatelli, Elizabeth R Sharlow, et al.
Pageof 2